Table 4 Explained variance of baseline values and effects of SF-36 and WOMAC by SOC-13 global score in a multivariate linear regression model
Baseline | Effect (Baseline → Discharge) | ||||
|---|---|---|---|---|---|
Explained Variance by SOC-13 (%) | Total Variance (%) | Explained Variance by SOC-13 (%) | Total Variance (%) | ||
SF-36 | Physical functioning | < 0.1 | 16.4 | 0.1 | 15.4 |
Role physical | 1.4 | 12.9 | < 0.1 | 13.5 | |
Bodily pain | 0.2 | 13.7 | 0.3 | 18.3 | |
General health | 12.2 | 20.5 | 0.1 | 15.5 | |
Vitality | 11.8 | 20.3 | 2.1 | 26.5 | |
Social functioning | 16.8 | 19.5 | < 0.1 | 25.5 | |
Role emotional | 19.8 | 21.4 | 0.7 | 26.9 | |
Mental health | 27.9 | 29.8 | 4.6 | 28.3 | |
PCS | 2.5 | 19.3 | < 0.1 | 15.1 | |
MCS | 32.8 | 34.4 | 2.1 | 26.7 | |
WOMAC | Pain | 4.4 | 13.9 | 0.7 | 14.0 |
Stiffness | 1.0 | 11.5 | 0.7 | 25.6 | |
Function | 2.0 | 16.4 | 0.6 | 12.2 | |
Global | 2.4 | 17.2 | 0.5 | 10.8 | |